Ronald Dorenbos Email & Phone Number

Boston, Ma, Us

Hamburg, De

Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.

Belmont, Massachusetts, Us

Driving innovation in the pharma industry.

Rensselaer, New York, Us

StemCultures has found a way to maintain control over stem cell growth factor levels. Now you can orchestrate culture conditions for higher quality cells while saving time and money.

Melbourne, Vic, Au

Resolutum Global is a clinical research organization (CRO) based in Australia that specializes in providing biometrics services for early phase and medical device clinical trials. As a data-focused biometrics CRO, Resolutum Global is primarily focused on data capture, data analysis, and reporting.

Solna, Solna, Se

EnginZyme is a Swedish startup with the vision to make the chemical industry green by unlocking the potential in enzymes. EnginZyme's cell-free biomanufacturing platform is created through a best-in-class approach that combines the breadth and power of biology and the efficiencies of the chemical industry. By replacing traditional fossil-based manufacturing with a cell-free technology platform, EnginZyme seeks to play a key role in solving one of the fundamental challenges of our time – how to produce better, greener, and cheaper products that we use every day.

Cambridge, Massachusetts, Us

At Vincere Biosciences, cutting-edge research focuses on the vital role of mitophagy in both Parkinson's disease and the aging process. By addressing deficient mitophagy, Vincere can usher in a new era of groundbreaking treatments.Vincere's innovative pipeline consists of small molecules designed to boost mitophagy, with the potential to become the first-ever medicines capable of slowing or stopping Parkinson's disease and other age-related conditions.By harnessing the power of advanced research, Vincere Biosciences aims to bring hope and transform the lives of those affected by these debilitating diseases.

Terra Bioforge is leveraging a portfolio of breakthrough proprietary tools andtechnology assets to scale production of microbial natural products faster and more efficiently.

Waltham, Massachusetts, Us

Advising Center for Health & Business on their AI in Life Sciences program.

Wilmington, Massachusetts, Us

Charles River Laboratories and Valo Health launched Logica, an artificial intelligence (AI) powered drug solution that directly translates clients’ biological insights into optimized preclinical assets. Logica leverages Valo’s AI-powered Opal Computational Platform and Charles River’s leading preclinical expertise, providing clients with transformed drug discovery with a single integrated offering seamlessly translating targets to candidate nomination. Feel free to connect to learn more about the way that AI-powered solutions can drive drug discovery forward to bring effective treatments to patients faster. Looking forward to being in touch.

Paris, France, Fr

Tokyo, Jp

* Identified and implemented new technologies and innovation across Takeda. * Structured deals and managed collaborations between Takeda and academic and industry partners.

Tokyo, Jp

Strengthening Takeda's pipeline with novel products and innovative technologies.

London, London, Gb

PA is a leading consulting, technology and innovation firm of over 2,500 people, operating globally from offices across North America, Europe, the Nordics, the Gulf and Asia Pacific. Its specific expertise is in energy and utilities, financial services, health, life sciences, consumer and manufacturing, government, defense and security, transport and logistics. In 2015, Carlyle Group bought 51% of the company and valued PA at $1B.

Cyclofluidic is a technology company founded by UCB and Pfizer and supported by the UK Technology Strategy Board (TSB) with the goal of improving the efficiency of drug discovery through the integration of chemistry and biology. The company uses an integrated microfluidic platform that combines both chemical synthesis and biological assay to rapidly deliver high quality molecules and data to feed the drug development pipeline.

Led collaboration between RXi & UMass to develop RNAi-based drugs for ALS (Lou Gehrig's Disease)

Boston, Ma, Us

Leading international collaborations between cross-functional teams doing research on Parkinson's Disease, Schizophrenia and the genetic basis of aggression.

Operations Management, Social Entrepreneurship, Chinese

Doctor Of Philosophy (Phd), Pharmaceutical Biology

Msc, Molecular Biology

Master'S Degree, Biotechnology